Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04634817 in adults with type 2 diabetes and overt nephropathy
2012-003332-23Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM) comparing PF-04634817 arm with Placebo arm (2 arms). Primary endpoint: Urinary albumin:creatinine ratio (UACR). Started Jan 2013; status: completed.
02
Drugs
PF-04634817
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-003332-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003332-23.